| Pseudomonas aeruginosa (NORTHEAST Data) | |||||||
| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | |
| ceftazidime | 80.8% n=4173 | 82.8% n=4155 | 78.4% n=4226 | 74.5% n=3922 | 74.8% n=2613 | 85.4% n=827 | |
| cefepime | 81.3% n=3017 | 87.4% n=2492 | 81% n=2897 | 78.7% n=3800 | 79.3% n=3642 | 87.1% n=2124 | |
| ciprofloxacin | 64.9% n=5624 | 67.2% n=4833 | 64.2% n=4909 | 65.8% n=4746 | 61.9% n=3654 | 67.4% n=1348 | |
| ofloxacin | 47.1% n=121 | 43.4% n=53 | |||||
| levofloxacin | 61.3% n=2957 | 65% n=3065 | 60.3% n=2922 | 61.9% n=3479 | 63% n=2978 | 64.3% n=1813 | |
| gatifloxacin | 65% n=489 | ||||||
| gentamicin | 74.7% n=5898 | 74.5% n=5453 | 72.4% n=5405 | 76.8% n=5651 | 79.9% n=4276 | 85.7% n=2159 | |
| tobramycin | 88.8% n=5581 | 88.2% n=4126 | 85.6% n=4628 | 88% n=3805 | 89.5% n=2141 | 93.1% n=1224 | |
| amikacin | 93.8% n=3183 | 90.3% n=3020 | 93.6% n=4561 | 93.4% n=4875 | 95.3% n=4017 | 96.9% n=1925 | |
| aztreonam | 62.6% n=2016 | 61.2% n=2073 | 62.5% n=2654 | 62.3% n=2381 | 67% n=1756 | 66.1% n=796 | |
| meropenem | 87.9% n=354 | 82.4% n=386 | 79.4% n=791 | 84.4% n=774 | 66.8% n=205 | 88% n=509 | |
| imipenem | 84.5% n=4084 | 85.8% n=3130 | 82.4% n=4430 | 80% n=4439 | 80.6% n=3985 | 86.7% n=1650 | |
| piperacillin | 84.7% n=1477 | 91.2% n=898 | 79.9% n=349 | 78.4% n=624 | 66.8% n=205 | 87.7% n=318 | |
| pip/taz | 88.8% n=4997 | 90% n=4448 | 89.4% n=5560 | 90% n=5573 | 92.7% n=4096 | 93% n=2159 | |
| Totals | 79.1% n=43482 | 79.5% n=38621 | 78.2% n=43332 | 78.6% n=44069 | 79.2% n=33568 | 84.1% n=16852 | |
This data is accurate as of: 11/22/2016 11:53:41 AM
Drugs with less than 10 isolates are removed from the chart and from the graph. The following drugs had some data removed: ofloxacin.
